131 related articles for article (PubMed ID: 27902324)
1. EBI2 expression in B lymphocytes is controlled by the Epstein-Barr virus transcription factor, BRRF1 (Na), during viral infection.
Cornaby C; Jafek JL; Birrell C; Mayhew V; Syndergaard L; Mella J; Cheney W; Poole BD
J Gen Virol; 2017 Mar; 98(3):435-446. PubMed ID: 27902324
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation.
Yoshida M; Watanabe T; Narita Y; Sato Y; Goshima F; Kimura H; Murata T
Sci Rep; 2017 Jul; 7(1):6044. PubMed ID: 28729695
[TBL] [Abstract][Full Text] [Related]
4. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
[TBL] [Abstract][Full Text] [Related]
5. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
6. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.
Hong GK; Delecluse HJ; Gruffat H; Morrison TE; Feng WH; Sergeant A; Kenney SC
J Virol; 2004 May; 78(10):4983-92. PubMed ID: 15113878
[TBL] [Abstract][Full Text] [Related]
7. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
8. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
9. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.
Segouffin-Cariou C; Farjot G; Sergeant A; Gruffat H
J Gen Virol; 2000 Jul; 81(Pt 7):1791-9. PubMed ID: 10859385
[TBL] [Abstract][Full Text] [Related]
11. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
Martin HJ; Lee JM; Walls D; Hayward SD
J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C.
Shimozuma Y; Ito T; Inokuchi M; Uchikoshi M; Miyashita M; Nozawa H; Shimazaki T; Hiroishi K; Imawari M
J Med Virol; 2010 Dec; 82(12):2064-72. PubMed ID: 20981794
[TBL] [Abstract][Full Text] [Related]
13. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity.
Rainio EM; Ahlfors H; Carter KL; Ruuska M; Matikainen S; Kieff E; Koskinen PJ
Virology; 2005 Mar; 333(2):201-6. PubMed ID: 15721354
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways.
D'Addario M; Libermann TA; Xu J; Ahmad A; Menezes J
J Mol Biol; 2001 May; 308(3):501-14. PubMed ID: 11327783
[TBL] [Abstract][Full Text] [Related]
15. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
16. EBV, the human host, and the 7TM receptors: defense or offense?
Arfelt KN; Fares S; Rosenkilde MM
Prog Mol Biol Transl Sci; 2015; 129():395-427. PubMed ID: 25595811
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.
Mrozek-Gorska P; Buschle A; Pich D; Schwarzmayr T; Fechtner R; Scialdone A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16046-16055. PubMed ID: 31341086
[TBL] [Abstract][Full Text] [Related]
18. [The entry of Epstein-Barr virus into B lymphocytes and epithelial cells during infection].
Zuo LL; Zhu MJ; Du SJ; Lu JH; Li GY
Bing Du Xue Bao; 2014 Jul; 30(4):476-82. PubMed ID: 25272606
[TBL] [Abstract][Full Text] [Related]
19. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
[TBL] [Abstract][Full Text] [Related]
20. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
Lavens S; Faust EA; Lu F; Jacob M; Leta M; Lieberman PM; Puré E
J Virol; 2004 Aug; 78(16):8543-51. PubMed ID: 15280463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
